These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29259370)

  • 1. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
    Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
    World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
    Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
    J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
    Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
    World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
    Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
    Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features.
    Thompson ED; Wood LD
    Arch Pathol Lab Med; 2020 Jul; 144(7):808-815. PubMed ID: 31869246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and genetics of pancreatic neoplasms with acinar differentiation.
    Wood LD; Klimstra DS
    Semin Diagn Pathol; 2014 Nov; 31(6):491-497. PubMed ID: 25441307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
    Mandelker D; Marra A; Zheng-Lin B; Selenica P; Blanco-Heredia J; Zhu Y; Gazzo A; Wong D; Yelskaya Z; Rai V; Somar J; Ostafi S; Mehta N; Yang C; Li Y; Brown DN; da Silva EM; Pei X; Linkov I; Terraf P; Misyura M; Ceyhan-Birsoy O; Ladanyi M; Berger M; Pareja F; Stadler Z; Offit K; Riaz N; Park W; Chou J; Capanu M; Koehler M; Rosen E; O'Reilly EM; Reis-Filho JS
    J Clin Oncol; 2023 Nov; 41(33):5151-5162. PubMed ID: 37607324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic acinar cell carcinoma: A comprehensive review.
    Calimano-Ramirez LF; Daoud T; Gopireddy DR; Morani AC; Waters R; Gumus K; Klekers AR; Bhosale PR; Virarkar MK
    World J Gastroenterol; 2022 Oct; 28(40):5827-5844. PubMed ID: 36353206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.
    Chmielecki J; Hutchinson KE; Frampton GM; Chalmers ZR; Johnson A; Shi C; Elvin J; Ali SM; Ross JS; Basturk O; Balasubramanian S; Lipson D; Yelensky R; Pao W; Miller VA; Klimstra DS; Stephens PJ
    Cancer Discov; 2014 Dec; 4(12):1398-405. PubMed ID: 25266736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases.
    Zhou W; Han X; Fang Y; Han S; Cai Y; Kuang T; Lou W; Wang D
    Cancer Control; 2020; 27(1):1073274820969447. PubMed ID: 33121259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
    Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
    Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
    Xu H; Wang X; Zhou S; Hu Q; Cao D
    Tumori; 2021 Dec; 107(6):NP24-NP27. PubMed ID: 33345750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
    Sanati S; Watson MA; Salavaggione AL; Humphrey PA
    Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
    Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
    J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
    La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
    Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
    Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
    J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review.
    Matsubayashi H; Todaka A; Tsushima T; Kiyozumi Y; Harada R; Ishihara E; Higashigawa S; Ohike N; Sakamoto H; Sato J; Ishiwatari H; Sugiura T; Uesaka K
    Fam Cancer; 2024 Aug; 23(3):393-398. PubMed ID: 38733420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.